The chart shows the distribution of publications by all Research.com ranked scientists in the field of Materials Science in 2026. The highlighted bar marks where Fumio Watari sits on this spectrum.
This scientist: 325 publications — 65th percentile
65% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,163 publications or more.
The chart shows the D-index (discipline H-index) distribution of Materials Science scientists ranked by Research.com in 2026. The highlighted bar marks where Fumio Watari sits on this spectrum.
This scientist: 68 D-Index — 63rd percentile
63% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 165 D-Index or more.
Fumio Watari is affiliated with Hokkaido University in Japan. Their research primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology, with a focus on oncology, molecular biology, and immunology as subfields of study.
The main topics addressed in their work include inflammatory biomarkers in disease prognosis, extracellular vesicles in disease, and immune cells in cancer. This thematic concentration highlights a focus on understanding the interactions between immune mechanisms and cancer progression, as well as the role of cellular components in disease diagnostics and therapy.
Watari's recent publication record includes a study titled "Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment", published in 2023 in the journal Acta Materia Medica. This paper explores the use of platelets as vectors for targeted drug delivery within cancer treatment frameworks, addressing their impact on the tumor microenvironment and immune modulation. The publication has been cited by other researchers, indicating engagement with the ongoing discourse in cancer immunotherapy and drug delivery systems.
Watari frequently collaborates with researchers such as Jie Guo, Mengfei Wang, Yong-Guan Zhu, Yong-Hong Xu, and Xiaohong Chen. These collaborations suggest a multidisciplinary approach and integration of expertise spanning molecular biology and clinical applications in oncology and immunology.
Their scholarly contributions have been documented mainly in the journal Acta Materia Medica, reflecting a focused presence within specialized scientific venues relevant to materials in medicine and related biomedical research.
Hironobu Matsuno;Atsuro Yokoyama;Fumio Watari;Motohiro Uo
Iosif Daniel Rosca;Fumio Watari;Motohiro Uo;Tsukasa Akasaka
Yoshinori Sato;Atsuro Yokoyama;Ken Ichiro Shibata;Yuki Akimoto
Iosif Daniel Rosca;Fumio Watari;Motohiro Uo
Fumio Watari;Atsuro Yokoyama;Mamoru Omori;Toshio Hirai
Susan Liao;Wei Wang;Motohiro Uo;Shoji Ohkawa
Xiaoming Li;Lu Wang;Yubo Fan;Qingling Feng
Xiaoming Li;Jianrong Wei;Katerina E Aifantis;Yubo Fan
Xiaoming Li;Haifeng Liu;Xufeng Niu;Bo Yu
Xiaoming Li;Clemens A. van Blitterswijk;Qingling Feng;Fuzhai Cui
Chun Lin;Bunshi Fugetsu;Youbo Su;Fumio Watari
Ryuichiro Kumazawa;Fumio Watari;Noriyuki Takashi;Yukihiro Tanimura
Tsukasa Akasaka;Fumio Watari
Xiaoming Li;Rongrong Cui;Lianwen Sun;Katerina E. Aifantis
Motohiro Uo;Morimichi Mizuno;Yoshinori Kuboki;Akio Makishima
Fumio Watari;Atsuro Yokoyama;Fuminori Saso;Motohiro Uo
Xiaoming Li;Hong Gao;Motohiro Uo;Yoshinori Sato
Li Zhao;Yong-Hong Xu;Tsukasa Akasaka;Shigeaki Abe
Bunshi Fugetsu;Shuya Satoh;Toshikazu Shiba;Taeko Mizutani
Xiaoming Li;Yubo Fan;Fumio Watari
If you think any of the details on this page are incorrect, let us know.
Wellcome Sanger Institute
RMIT University
Erasmus University Rotterdam
University of Liverpool
Tokyo Medical and Dental University
University at Buffalo, State University of New York
University of Pennsylvania
Massey University
Rigshospitalet
TU Wien
Shaanxi University of Science and Technology
University of Bristol
University of California, Santa Barbara
Purdue University West Lafayette
Hanken School of Economics
University of Turku
